0001437749-24-009052.txt : 20240322 0001437749-24-009052.hdr.sgml : 20240322 20240322161744 ACCESSION NUMBER: 0001437749-24-009052 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240322 DATE AS OF CHANGE: 20240322 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eton Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001710340 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 371858472 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38738 FILM NUMBER: 24775481 BUSINESS ADDRESS: STREET 1: 21925 W. FIELD PARKWAY STREET 2: SUITE 235 CITY: DEER PARK STATE: IL ZIP: 60010-7278 BUSINESS PHONE: (847) 787-7361 MAIL ADDRESS: STREET 1: 21925 W. FIELD PARKWAY STREET 2: SUITE 235 CITY: DEER PARK STATE: IL ZIP: 60010-7278 10-K/A 1 eton20231130_10ka.htm FORM 10-K/A eton20231130_10ka.htm
true 0001710340 0001710340 2023-01-01 2023-12-31 0001710340 2023-06-30 0001710340 2024-03-21 iso4217:USD xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-K/A
(Amendment No. 1)
 
(Mark One)
 
☒
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the fiscal year ended December 31, 2023
--12-31FY2023
 
OR
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
FOR THE TRANSITION PERIOD FROM ______ TO ______
 
Commission File Number 001-38738
 
ETON PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
37-1858472
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer
Identification No.)
 
21925 W. Field Parkway, Suite 235
Deer Park, IL
60010-7278
(Address of principal executive offices)
(Zip Code)
 
Registrant’s telephone number, including area code: (847) 787-7361
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading Symbol
  
Name of each exchange on which registered
Common Stock, $0.001 par value
  
ETON
  
The Nasdaq Global Market LLC
 
Securities registered pursuant to Section 12(g) of the Act: None
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒
 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐ No ☒
 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
 
 
 
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
☐
  
Accelerated filer
☐
Non-accelerated filer
☒
  
Smaller reporting company
☒
     
Emerging growth company
☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐
 
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐
 
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
 
The aggregate market value of all common stock (based upon the closing price on the Nasdaq Global Market) of the registrant held by non-affiliates as of June 30, 2023 was approximately $84.7 million.
 
As of March 21, 2024, the registrant had 25,688,062 shares of common stock, $0.001 par value per share, outstanding.
 
DOCUMENTS INCORPORATED BY REFERENCE
 
Portions of the registrant’s definitive proxy statement for its 2024 Annual Meeting of Stockholders, which the registrant intends to file pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant’s fiscal year ended December 31, 2023, are incorporated by reference into Part III of the Annual Report on Form 10-K.
 
 
 
 
EXPLANATORY NOTE
 
Eton Pharmaceuticals, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (the “Amended 10-K”) to amend the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Original 10-K”), originally filed with the Securities and Exchange Commission (the “SEC”) on March 14, 2023, solely to amend the Consent of KMJ Corbin & Company LLP, Irvine, California, PCAOB ID: 170, the Company's Independent Registered Public Accounting Firm, included as Exhibit No. 23.1.
 
Except as described above, no other amendments are being made to the Original 10-K. This Amended 10-K does not reflect events occurring after the filing of the Original 10-K or modify or update the disclosure contained therein in any way other than as required to reflect the amendments discussed above.
 
The Company has attached to this Amended 10-K updated certifications executed as of the date of this Amended 10-K by the Principal Executive Officer and Principal Financial Officer as required by Sections 302 and 906 of the Sarbanes Oxley Act of 2002. These updated certifications are attached as Exhibits 31.1/31.2 and 32.1 to this Amended 10-K.
 
Item 15. Exhibits, Financial Statement Schedules
 
(1) Exhibits
 
The following exhibits are being filed herewith and are numbered in accordance with Item 601 of Regulation S-K:
 
EXHIBIT INDEX
 
 
Exhibit No.
  
Description
23.1
  
31.1
  
31.2
  
32.1
  
101*   The following financial information from the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) the Balance Sheets, (ii) the Statements of Operations, (iii) the Statement of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit), (iv) the Statements of Cash Flows and (v) Notes to Financial Statements.
104   The cover page from the Company's Annual Report on Form 10-K/A for the year ended December 31, 2023, formatted in Inline XBRL (included as Exhibit 101)
 
* Previously filed
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Amendment to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
ETON PHARMACEUTICALS, INC.
     
March 22, 2024
By:
/s/ Sean E. Brynjelsen
   
Sean E. Brynjelsen
   
President and Chief Executive Officer
   
(Principal Executive Officer)
     
 
By:
/s/ James Gruber
   
James Gruber
   
Chief Financial Officer
   
(Principal Financial and Accounting Officer)
 
 
 
 
 EX-23.1 2 ex_642689.htm EXHIBIT 23.1 ex_642689.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in Registration Statement Nos. 333-228493, 333-230572, and 333-270707 on Form S-8 and Registration Statement No. 333-240252 on Form S-3 of our report dated March 14, 2024, relating to the financial statements of Eton Pharmaceuticals, Inc., appearing in this Annual Report on Form 10-K of Eton Pharmaceuticals, Inc. for the year ended December 31, 2023.

 

/s/ KMJ Corbin & Company LLP

 

Irvine, California

March 18, 2024

 

 

 
 EX-31.1 3 ex_642690.htm EXHIBIT 31.1 ex_642690.htm

Exhibit 31.1

 

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Sean E. Brynjelsen, certify that:

 

1. I have reviewed this Amendment to Form 10-K of Eton Pharmaceuticals, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 22, 2024

By:

/s/ Sean E. Brynjelsen
   

Sean E. Brynjelsen
   

Principal Executive Officer

 

 

 
 EX-31.2 4 ex_642691.htm EXHIBIT 31.2 ex_642691.htm

Exhibit 31.2

 

 

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, James Gruber, certify that:

 

1. I have reviewed this Amendment to Form 10-K of Eton Pharmaceuticals, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 22, 2024

By:

/s/ James Gruber
   

James Gruber
   

Principal Financial and Accounting Officer

 

 

 

 
 EX-32.1 5 ex_642692.htm EXHIBIT 32.1 ex_642692.htm

Exhibit 32.1

 

ETON PHARMACEUTICALS, INC.
PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Sean E. Brynjelsen, President and Chief Executive Officer of Eton Pharmaceuticals, Inc. (the “Company”), and James Gruber, Chief Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:

 

1. The Company’s Amendment to Form 10-K for the period ended December 31, 2023 (the “Amended 10-K”), to which this Certification is attached as Exhibit 32.1, fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and

 

2. The information contained in the Amended 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

IN WITNESS WHEREOF, the undersigned have set their hands hereto as of the 22nd day of March, 2024.

 

/s/ Sean E. Brynjelsen

  

/s/ James Gruber

Sean E. Brynjelsen

  

James Gruber

President and Chief Executive Officer

(Principal Executive Officer)

  

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

*

This certification accompanies the Amended 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Amended 10-K), irrespective of any general incorporation language contained in such filing.

 

 

 
 EX-101.SCH 6 eton-20231231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 7 eton-20231231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 8 eton-20231231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Annual Report Document, Period End Date Current Fiscal Year End Date Document, Fiscal Period Focus Document, Fiscal Year Focus Document, Transition Report Entity, File Number Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity, Well-known Seasoned Issuer Entity, Voluntary Filers Entity, Current Reporting Status Entity, Interactive Data, Current Entity, Filer Category Entity, Small Business Entity, Emerging Growth Company ICFR Auditor Attestation Flag Document, Financial Statement Error Correction Flag Entity, Shell Company Entity, Public Float Entity, Common Stock Shares, Outstanding Amendment Description Amendment Flag Entity, Central Index Key EX-101.PRE 9 eton-20231231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Document And Entity Information - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Mar. 21, 2024
Jun. 30, 2023
Document Information [Line Items]      
Entity, Registrant Name ETON PHARMACEUTICALS, INC.    
Document, Type 10-K/A    
Document, Annual Report true    
Document, Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document, Fiscal Period Focus FY    
Document, Fiscal Year Focus 2023    
Document, Transition Report false    
Entity, File Number 001-38738    
Entity, Incorporation, State or Country Code DE    
Entity, Tax Identification Number 37-1858472    
Entity, Address, Address Line One 21925 W. Field Parkway, Suite 235    
Entity, Address, City or Town Deer Park    
Entity, Address, State or Province IL    
Entity, Address, Postal Zip Code 60010-7278    
City Area Code 847    
Local Phone Number 787-7361    
Title of 12(b) Security Common Stock, $0.001 par value    
Trading Symbol ETON    
Security Exchange Name NASDAQ    
Entity, Well-known Seasoned Issuer No    
Entity, Voluntary Filers No    
Entity, Current Reporting Status Yes    
Entity, Interactive Data, Current Yes    
Entity, Filer Category Non-accelerated Filer    
Entity, Small Business true    
Entity, Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document, Financial Statement Error Correction Flag false    
Entity, Shell Company false    
Entity, Public Float     $ 84.7
Entity, Common Stock Shares, Outstanding   25,688,062  
Amendment Description Eton Pharmaceuticals, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (the “Amended 10-K”) to amend the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Original 10-K”), originally filed with the Securities and Exchange Commission (the “SEC”) on March 14, 2023, solely to amend the Consent of KMJ Corbin & Company LLP, Irvine, California, PCAOB ID: 170, the Company's Independent Registered Public Accounting Firm, included as Exhibit No. 23.1.   Except as described above, no other amendments are being made to the Original 10-K. This Amended 10-K does not reflect events occurring after the filing of the Original 10-K or modify or update the disclosure contained therein in any way other than as required to reflect the amendments discussed above.   The Company has attached to this Amended 10-K updated certifications executed as of the date of this Amended 10-K by the Principal Executive Officer and Principal Financial Officer as required by Sections 302 and 906 of the Sarbanes Oxley Act of 2002. These updated certifications are attached as Exhibits 31.1/31.2 and 32.1 to this Amended 10-K.    
Amendment Flag true    
Entity, Central Index Key 0001710340    
EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 13 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 16 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 3 35 1 false 0 0 false 2 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.eton.com/20231231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports eton-20231231.xsd eton-20231231_def.xml eton-20231231_lab.xml eton-20231231_pre.xml eton20231130_10ka.htm http://xbrl.sec.gov/dei/2023 true false JSON 18 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "eton20231130_10ka.htm": { "nsprefix": "eton", "nsuri": "http://www.eton.com/20231231", "dts": { "schema": { "local": [ "eton-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "definitionLink": { "local": [ "eton-20231231_def.xml" ] }, "labelLink": { "local": [ "eton-20231231_lab.xml" ] }, "presentationLink": { "local": [ "eton-20231231_pre.xml" ] }, "inline": { "local": [ "eton20231130_10ka.htm" ] } }, "keyStandard": 35, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 0, "elementCount": 39, "unitCount": 2, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 35 }, "report": { "R1": { "role": "http://www.eton.com/20231231/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d202410KA", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "eton20231130_10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d202410KA", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "eton20231130_10ka.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r3", "r4", "r5" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Financial Statement Error Correction Flag", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r3", "r4", "r5", "r7" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r6" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Common Stock Shares, Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r1" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Interactive Data, Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r8" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r1" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r9" ] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r3", "r4", "r5" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.eton.com/20231231/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" } } } ZIP 19 0001437749-24-009052-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-24-009052-xbrl.zip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eton20231130_10ka_htm.xml IDEA: XBRL DOCUMENT 0001710340 2023-01-01 2023-12-31 0001710340 2023-06-30 0001710340 2024-03-21 iso4217:USD shares true 0001710340 10-K/A true 2023-12-31 --12-31 FY 2023 false 001-38738 ETON PHARMACEUTICALS, INC. DE 37-1858472 21925 W. Field Parkway, Suite 235 Deer Park IL 60010-7278 847 787-7361 Common Stock, $0.001 par value ETON NASDAQ No No Yes Yes Non-accelerated Filer true false false false false 84700000 25688062 Eton Pharmaceuticals, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (the “Amended 10-K”) to amend the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Original 10-K”), originally filed with the Securities and Exchange Commission (the “SEC”) on March 14, 2023, solely to amend the Consent of KMJ Corbin & Company LLP, Irvine, California, PCAOB ID: 170, the Company's Independent Registered Public Accounting Firm, included as Exhibit No. 23.1.   Except as described above, no other amendments are being made to the Original 10-K. This Amended 10-K does not reflect events occurring after the filing of the Original 10-K or modify or update the disclosure contained therein in any way other than as required to reflect the amendments discussed above.   The Company has attached to this Amended 10-K updated certifications executed as of the date of this Amended 10-K by the Principal Executive Officer and Principal Financial Officer as required by Sections 302 and 906 of the Sarbanes Oxley Act of 2002. These updated certifications are attached as Exhibits 31.1/31.2 and 32.1 to this Amended 10-K.